Related Experiment Video
Updated: Oct 22, 2025

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
Published on: June 14, 2016
Calpain-Mediated Mitochondrial Damage: An Emerging Mechanism Contributing to Cardiac Disease
Mengxiao Zhang1,2,3, Grace Wang4, Tianqing Peng3,5,6
1Institutes of Biology and Medical Sciences, Soochow University, Suzhou 215123, China.
Abstract:
Calpains belong to the family of calcium-dependent cysteine proteases expressed ubiquitously in mammals and many other organisms. Activation of calpain is observed in diseased hearts and is implicated in cardiac cell death, hypertrophy, fibrosis, and inflammation. However, the underlying mechanisms remain incompletely understood. Recent studies have revealed that calpains target and impair mitochondria in cardiac disease. The objective of this review is to discuss the role of calpains in mediating mitochondrial damage and the underlying mechanisms, and to evaluate whether targeted inhibition of mitochondrial calpain is a potential strategy in treating cardiac disease. We expect to describe the wealth of new evidence surrounding calpain-mediated mitochondrial damage to facilitate future mechanistic studies and therapy development for cardiac disease.
Insights
Calpains, calcium-dependent proteases, damage mitochondria in heart disease. Targeting mitochondrial calpain may offer a new therapeutic strategy for cardiac conditions.
Area of Science:
- Biochemistry
- Cardiovascular Biology
- Cell Biology
Background:
- Calpains are calcium-dependent cysteine proteases found in many organisms.
- Calpain activation is linked to cardiac dysfunction, including cell death, hypertrophy, fibrosis, and inflammation.
- The precise mechanisms of calpain's role in cardiac disease are not fully understood.
Purpose of the Study:
- To review the role of calpains in causing mitochondrial damage in cardiac disease.
- To explore the mechanisms underlying calpain-mediated mitochondrial impairment.
- To assess the potential of inhibiting mitochondrial calpain as a therapeutic approach for cardiac disease.
Main Methods:
- Literature review of recent studies on calpains and cardiac disease.
- Analysis of evidence implicating calpains in mitochondrial dysfunction.
- Evaluation of therapeutic strategies targeting mitochondrial calpains.
Main Results:
- Calpains have been identified as key mediators of mitochondrial damage in cardiac disease.
- Specific mechanisms of calpain-induced mitochondrial injury are being elucidated.
- Emerging evidence suggests mitochondrial calpain inhibition as a promising therapeutic avenue.
Conclusions:
- Calpain-mediated mitochondrial damage is a significant factor in cardiac pathology.
- Further research into these mechanisms can guide the development of novel therapies.
- Targeting mitochondrial calpains holds potential for treating various cardiac diseases.
Related Concept Videos
Pathophysiology of Heart Failure
ATP Synthase: Mechanism
Myocarditis I: Introduction
Pathophysiology of Cardiac Performance
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
Cardiomyopathy I: Introduction and Classification

